Consumer Protection

FDA Recall Exposes Dangerous Cancer-Causing Contamination in Blood Pressure Drug

By Economics Desk | October 31, 2025

The FDA reveals a widespread recall of prazosin hydrochloride due to nitrosamine impurities linked to cancer, raising urgent concerns about pharmaceutical safety and regulatory oversight.

The recent recall of more than half a million bottles of the blood pressure medication prazosin hydrochloride by Teva Pharmaceuticals USA and Amerisource Health Services should sound alarm bells for every American relying on our healthcare system. The U.S. Food and Drug Administration (FDA) has confirmed that these pills contain potentially cancer-causing nitrosamine impurities—chemicals that should never be found in medications designed to protect our health. Prazosin, prescribed not only for hypertension but also for PTSD-related nightmares, is widely used by vulnerable patients across the country. Yet instead of the safeguard it promises, this medication may be silently endangering lives...

This is Exclusive Content for Subscribers

Join our community of patriots to read the full story and get access to all our exclusive analysis.

View Subscription Plans